The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital

Dr Michael Hall

Michael completed his PhD in March 2022 in the lab of Zamin Iqbal at the University of Cambridge. His thesis focused on developing computational methods for analysing bacterial pan-genomes and applying these to Mycobacterium tuberculosis. Michael is currently a postdoctoral researcher in Lachlan Coin’s lab at the Peter Doherty Institute. He continues to work on computational methods for M. tuberculosis analysis – with a current focus on drug resistance prediction.

  • Key Achievements
    • Best Lightning Talk – ABACBS Conference 2022

      The Master of Molecular Biology and Master of Bioinformatics Prize – The  University of Queensland

      Westpac Future Leaders Scholarship 2016

      Winner - 2016 Brisbane HealthHack

    Loading ORCID data…
    Research Groups
    • Coin group

      The Coin Group develops genomic and transcriptomic tools to develop biomarkers for rapid characterization of disease state and prediction of drug susceptibility, with the aim of decreasing the time taken from hospital admission to administering the right treatment. We currently focus on infectious disease as well as cancer.    

      Lab Team

      • Dr Chenxi Zhou
        Postdoctoral Researcher
      • Dr Devika Ganesamoorthy
        Postdoctoral Researcher
      • Postdoctoral Research Officer
      • Postdoctoral Fellow
      • Jessie Chang
        PhD Student
      • Bioinformatician & PhD Candidate